Pricing

Log inSign up

Y-mAbs Therapeutics

0 followers

‌

Y-mAbs is a late-stage clinical biopharmaceutical company focused on the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer.

Industries

Biotechnology

Headquarters

New York, United States

Employees

51-200

Links

Org chart

TG
Thomas Gad
Chairman & CEO

Thomas Gad

Collapse
Vignesh Rajah
SVP & CMO
Joris Wilms
SVP & COO
SS
Sue Smith
SVP & Chief Commercial Officer
Christopher Naylor
Senior Director, Head of Human Resources
RL
Rikke Lillesø
Vice President
SN
Sune Nyland
VP, General Counsel
TS
Tore Søderblom
VP CMC development
Courtney Dugan
Vice President, Head of Investor Relations
Robert Gunning
VP, Finance and Corporate Controller
Peter Pfreundschuh
Chief Financial Officer
CR
Charlotte A. Russell
Senior Medical Director
Karen Tornøe
Senior Medical Director

Board & advisors

Johan Wedell-Wedellsborg
Director
GB
Gérard Ber
Director
AT
Ashutosh Tyagi
Director
JH
James I. Healy
Director
DG
David N. Gill
Director
Laura J. Hamill
Director

Teams

+14

Scientific Research and Development

17 members

+11

Leadership Team

14 members

CG
+4

Sales and Account Management

7 members

+4

Clinical and Medical Operations

7 members

+4

Marketing and Commercial Strategy

7 members

Finance and Accounting

2 members

Offices

Similar companies

Kura Oncology

20 followers

Halozyme Therapeutics

6 followers

Immunovant

6 followers

REVOLUTION Medicines

5 followers

C4 Therapeutics

5 followers

Summit Therapeutics

5 followers

Inari

3 followers

Beta Bionics

3 followers

Arcturus Therapeutics

2 followers

Tenaya Therapeutics

2 followers

Generation Bio

2 followers

Explore companies